Delivery Order SPE2DB20D3101-SPE2DB25FRKU5
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,374.50 for Shingrix vial kits under a Firm Fixed Price contract by the Defense Logistics Agency's Medical Supply Chain on September 19, 2025, with an ultimate completion date of September 22, 2025. The award carries no set-aside designation and represents a competitive procurement. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,357.35 by the Defense Logistics Agency (DLA) for Shingrix vial kits, with an ultimate completion date of August 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader federal contracting relationship with DLA. This award falls...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,559.19 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Shingrix vial kits. This is a firm fixed price, competitively awarded contract with a completion date of August 5, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $8,769.12, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,391.80 by the Defense Logistics Agency on July 21, 2025, for the supply of Shingrix vial kits. This firm fixed-price contract represents a non-set-aside competitive award with an ultimate completion date of July 22, 2025. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,355.01 on September 3, 2025, for the supply of Shingrix vial kits. This competitively awarded, firm fixed-price contract is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 4, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Shingrix vial kits, with a ceiling value of $1,544.06. This firm fixed-price delivery order is set to be completed by April 25, 2025, and represents a non-competitive continuation of AmerisourceBergen's substantial federal pharmaceutical supply relationship. The award is issued under a child contract vehicle, leveraging AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.18 to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 1, 2025. This firm fixed price contract, awarded on July 31, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The contract was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $8,301.01 firm fixed-price delivery order by the Defense Logistics Agency on July 15, 2025, for the supply of Shingrix vial kits. The contract is non-competitive and classified as a child award, indicating it derives from a larger indefinite delivery vehicle. This delivery order will be fulfilled at the contractor's corporate office location in Conshohocken, PA, with an ultimate completion date of July 16,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,993.51 for Shingrix vial kits on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, fulfilling this...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRKU5Delivery Order
AmerisourceBergen Drug Corp was awarded a $5,695.90 firm fixed-price delivery order by the Defense Logistics Agency on May 20, 2025, for the supply of Shingrix vial kits. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of May 21, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. As a prime vendor under the DLA Troop Support Medical's comprehensive pharmaceutical support vehicle, the company supplies a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. This Shingrix delivery order is consistent with the contractor's extensive portfolio of federal medical procurements, which demonstrate its capability to fulfill diverse pharmaceutical supply requirements through open competition and firm fixed-price arrangements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 5/20/25 |